Antitrypanosomal isothiocyanate and thiocarbamate glycosides from moringa peregrina

Planta Medica

Volumn 80, Issue 1, 2014, Pages 86-89

  Ayyari, Mahdi ^a   Salehi, Peyman ^a   Ebrahimi, Samad Nejad ^a,b   Zimmermann, Stefanie ^b,c   Portmann, Lena ^b   Krauth Siegel, R Luise ^d   Kaiser, Marcel ^b,c   Brun, Reto ^b,c   Rezadoost, Hassan ^a   Rezazadeh, Shamsali ^e   Hamburger, Matthias ^b  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

^b UNIVERSITY OF BASEL   (Switzerland)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

isothiocyanate; Moringa peregrina; Moringaceae; thiocarbamate glycoside; Trypanosoma brucei rhodesiense

Indexed keywords

4 (ALPHA LEVO RHAMNOSYLOXY)BENZYL ISOTHIOCYANATE; ANTITRYPANOSOMAL AGENT; GLYCOSIDE; ISOTHIOCYANIC ACID DERIVATIVE; NIAZIMICIN; NIAZIN A; O BUTYL 4 [(ALPHA LEVO RHAMNOSYLOXY)BENZYL]THIOCARBAMATE; THIOCARBAMIC ACID DERIVATIVE; TRYPANOTHIONE REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; IC 50; IN VITRO STUDY; IN VIVO STUDY; MORINGA; MORINGA PEREGRINA; MOUSE; MYOBLAST; NONHUMAN; PARASITEMIA; RAT; REVIEW; TRYPANOSOMA RHODESIENSE;

ANIMALIA; MORINGA PEREGRINA; MORINGACEAE; RATTUS; TRYPANOSOMA BRUCEI RHODESIENSE;

ANIMALS; DISEASE MODELS, ANIMAL; GLYCOSIDES; INJECTIONS, INTRAPERITONEAL; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOLECULAR STRUCTURE; MORINGA; MYOBLASTS, SKELETAL; NADH, NADPH OXIDOREDUCTASES; PLANT COMPONENTS, AERIAL; RATS; RHAMNOSE; THIOCARBAMATES; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 84892432583     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1351102     Document Type: Review

References (27)

1. Brun R., Blum J., Chappuis F., Burri C. Human African trypanosomiasis. Lancet: 2009; 375 148 159
2. Burri C., Brun R. Human African trypanosomiasis. In: Gordon C. C., Zumla A. I. editors Manson's Tropical diseases. 22nd edition. Amsterdam Saunders Elsevier: 2009; 1307 1325
3. Dastan D., Salehi P., Reza Gohari A., Zimmermann S., Kaiser M., Hamburger M., Reza Khavasi H., Ebrahimi S. N. Disesquiterpene and sesquiterpene coumarins from Ferula pseudalliacea, and determination of their absolute configurations. Phytochemistry: 2012; 78 170 178
4. Zimmermann S., Kaiser M., Brun R., Hamburger M., Adams M. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei. Planta Med: 2012; 78 553 556
5. Adams M., Zimmermann S., Kaiser M., Brun R., Hamburger M. A protocol for HPLC-based activity profiling for natural products with activities against tropical parasites. Nat Prod Commum: 2009; 4 1377
6. Mekonnen Y., Yardley V., Rock P., Croft S. In vitro antitrypanosomal activity of Moringa stenopetala leaves and roots. Phytother Res: 1999; 13 538 539 (Pubitemid 29445778)
7. Elbatran S. A., Abdel-Salam O. M., Abdelshfeek K. A., Nazif N. M., Ismail S. I., Hammouda F. M. Phytochemical and pharmacological investigations on Moringa peregrina (Forssk) Fiori. Nat Prod Sci: 2005; 11 1 8
8. Bennett R. N., Mellon F. A., Foidl N., Pratt J. H., Dupont M. S., Perkins L., Kroon P. A. Profiling glucosinolates and phenolics in vegetative and reproductive tissues of the multi-purpose trees Moringa oleifera L. (horseradish tree) and Moringa stenopetala L. J Agric Food Chem: 2003; 51 3546 3553
9. Anwar F., Latif S., Ashraf M., Gilani A. H. Moringa oleifera: a food plant with multiple medicinal uses. Phytother Res: 2007; 21 17 25 (Pubitemid 46173903)
10. Fahey J. W., Zalcmann A. T., Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry: 2001; 56 5 51 (Pubitemid 32063165)
11. Faizi S., Siddiqui B. S., Saleem R., Siddiqui S., Aftab K. Isolation and structure elucidation of novel hypotensive agents, niazinin A, niazinin B, niazimicin and niaziminin A+ B from Moringa oleifera: the first naturally occurring thiocarbamates. J Chem Soc [Perkin I]: 1992; 3237 3241
12. Krauth-Siegel R. L., Comini M. A. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism. Biochim Biophys Acta: 2008; 1780 1236 1248
13. Kjær A., Malver O., El-menshawi B., Reischt J. Isothiocyanates in myrosinase-treated seed extracts of Moringa peregrina. Phytochemistry: 1979; 18 1485 1487
14. Eilert U., Wolters B., Nahrstedt A. The antibiotic principle of seeds of Moringa oleifera and Moringa stenopetala. Planta Med: 1981; 42 55 61 (Pubitemid 11077171)
15. Shikita M., Fahey J. W., Golden T. R., Holtzclaw W. D., Talalay P. An unusual case of 'uncompetitive activation' by ascorbic acid: purification and kinetic properties of a myrosinase from Raphanus sativus seedlings. Biochem J: 1999; 341 725 732 (Pubitemid 29389204)
16. Zhang Y., Talalay P. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Cancer Res: 1998; 58 4632 4639 (Pubitemid 28480628)
17. Mahéo K., Morel F., Langouët S., Kramer H., Le Ferrec E., Ketterer B., Guillouzo A. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res: 1997; 57 3649 3652 (Pubitemid 27381200)
18. Saleem R., Meinwald J. Synthesis of novel hypotensive aromatic thiocarbamate glycosides. J Chem Soc [Perkin I]: 2000; 391 394 (Pubitemid 35290352)
19. Faizi S., Siddiqui B. S., Saleem R., Siddiqui S., Aftab K., Gilani A. H. Novel hypotensive agents, niazimin A, niazimin B, Niazicin A and Niazicin B from Moringa oleifera: isolation of first naturally occurring carbamates. J Chem Soc [Perkin I]: 1994; 3035 3040
20. Leuck M., Kunz H. Synthesis of active principles from the leaves of Moringa oleifera using S -pent-4-enyl thioglycosides. Carbohydr Res: 1998; 312 33 44 (Pubitemid 28529408)
21. Bauman R. A. Cis-trans isomerism of thionocarbamate esters. J Org Chem: 1967; 32 4129 4132
22. Fueller F., Jehle B., Putzker K., Lewis J. D., Krauth-Siegel R. L. High throughput screening against the peroxidase cascade of African trypanosomes identifies antiparasitic compounds that inactivate tryparedoxin. J Biol Chem: 2012; 287 8792 8802
23. Nibret E., Wink M. Trypanocidal and antileukaemic effects of the essential oils of Hagenia abyssinica, Leonotis ocymifolia, Moringa stenopetala, and their main individual constituents. Phytomedicine: 2010; 17 911 920
24. Hannaert V. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems. Planta Med: 2011; 77 586 597
25. Schmidt T. J., Khalid S. A., Romanha A. J., Alves T. M., Biavatti M. W., Brun R., Da Costa F. B., de Castro S. L., Ferreira V. F., de Lacerda M. V., Lago J. H., Leon L. L., Lopes N. P., das Neves Amorim R. C., Niehues M., Ogungbe I. V., Pohlit A. M., Scotti M. T., Setzer W. N., Soeiro M. DNC, Steindel M., Tempone A. G. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I. Curr Med Chem: 2012; 19 2128 2175
26. Schmidt T. J., Khalid S. A., Romanha A. J., Alves T. M., Biavatti M. W., Brun R., Da Costa F. B., De Castro S. L., Ferreira V. F., De Lacerda M. VG, Lago J. HG, Leon L. L., Lopes N. P., Amorim R. CDN, Niehues M., Ogungbe I. V., Pohlit A. M., Scotti M. T., Setzer W. N., Soeiro M. DNC, Steindel M., Tempone A. G. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II. Curr Med Chem: 2012; 19 2176 2228
27. Jockers-Scherübl M. C., Schirmer R. H., Krauth-Siegel R. L. Trypanothione reductase from Trypanosoma cruzi, catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. Eur J Biochem: 1989; 180 267 272 (Pubitemid 19088813)